Bio Green Med Solution, Inc. (BGMS): who owns it and who trades it
As of Nov 16, 2026, no open-market insider purchases or sales of BGMS were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
No BGMS insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
BGMS short interest
Low short interest. 0.4% of BGMS shares are sold short: about 1 share in 244. Over the last 12 reports the number of shares short went up 3%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 27,116 BGMS shares were sold short, 0.4% of the shares outstanding, down 10.2% from the report before. At the average daily volume of 23,253 shares, buying them all back would take about 1.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 27,116 | 0.41% | -10% | 23,253 | 1.2 |
| Oct 15, 2026 | 30,190 | 0.46% | +440% | 39,784 | 1.0 |
| Sep 30, 2026 | 5,591 | 0.08% | -94% | 21,117 | 1.0 |
| Sep 15, 2026 | 90,785 | 1.37% | +160% | 332,530 | 1.0 |
| Aug 31, 2026 | 34,897 | 0.53% | -40% | 13,850 | 2.5 |
| Aug 14, 2026 | 58,435 | 0.88% | -12% | 39,839 | 1.5 |
| Jul 31, 2026 | 66,628 | 1.21% | -34% | 31,323 | 2.1 |
| Jul 15, 2026 | 101,272 | 1.83% | -1% | 95,963 | 1.1 |
| Jun 30, 2026 | 102,058 | 1.85% | -47% | 212,492 | 1.0 |
| Jun 15, 2026 | 193,285 | 3.50% | +514% | 12.41M | 1.0 |
| May 29, 2026 | 31,498 | 0.57% | +20% | 36,838 | 1.0 |
| May 15, 2026 | 26,327 | 0.48% | -28% | 36,472 | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Bio Green Med Solution company events
Bio Green Med Solution filed 12 reports on Form 8-K in the last 12 months, 2 of them about an important change (listing). The latest was on Nov 4, 2026.
- Nov 4, 2026ListingGot a notice from its stock exchange about its listing, or moved its listing. Filing
- Oct 16, 2026AnnouncementThe Board of Directors of Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock. Filing
- Aug 14, 2026ResultsReleased financial results. Filing
- Jul 1, 2026AnnouncementThe Board of Directors of Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock. Filing
- Jun 22, 2026VoteReported shareholder vote results. Filing
- Jun 10, 2026AgreementBio Green Med Solution, Inc. entered into a Securities Purchase Agreement with certain foreign accredited investors, pursuant to which the Investors agreed to purchase from the Company an aggregate of 1,103,338 shares of Common Stock, par value $0.001 of the Company at a purchase price of $0.72 per… Filing
- Jun 4, 2026AgreementBio Green Med Solution, Inc., a Delaware corporation, Future NRG Sdn. Filing
- May 14, 2026ResultsReleased financial results. Filing
- Apr 13, 2026AnnouncementThe Board of Directors of Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock. Filing
- Mar 30, 2026ResultsReleased financial results. Filing
- Mar 13, 2026ListingAs previously disclosed, on September 11, 2025, Bio Green Med Solution, Inc. received a letter from the listing qualifications department staff of The Nasdaq Stock Market, notifying the Company that its 6% Convertible Exchangeable Preferred Stock (listed on The Nasdaq Capital Market under the… Filing
- Jan 12, 2026AnnouncementThe Board of Directors of Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Bio Green Med Solution financials
Famous investors that hold BGMS
1 of the 50 well-known investors we track reported holding BGMS in their latest 13F filing. The largest position is Ken Griffin's, worth $27.2K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 30,788 | $27.2K | 0.0% | -59% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Bio Green Med Solution, Inc. (BGMS) stock
Are BGMS insiders buying or selling?
No BGMS insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in BGMS?
As of Oct 30, 2026, 27,116 BGMS shares were sold short, 0.4% of the shares outstanding, down 10.2% from the report before. At the average daily volume of 23,253 shares, buying them all back would take about 1.2 trading days (days to cover). See the history.
Which famous investors hold BGMS?
1 of the 50 well-known investors we track reported BGMS in their latest 13F filing, including Ken Griffin. The largest position is worth $27.2K. See all holders.
Executive pay
Bio Green Med Solution's chief executive was paid a total of $585K for the year ended Dec 31, 2024, down 12% from $661K the year before. In the last 12 months, Bio Green Med Solution's executives and directors bought no stock on the open market and sold none.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.